BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7731678)

  • 1. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of Ras-Raf association by short peptides.
    Barnard D; Sun H; Baker L; Marshall MS
    Biochem Biophys Res Commun; 1998 Jun; 247(1):176-80. PubMed ID: 9636675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small peptide derived from the aminoterminus of c-Raf-1 inhibits c-Raf-1/Ras binding.
    Niehof M; Radziwill G; Klauser S; Moelling K
    Biochem Biophys Res Commun; 1995 Jan; 206(1):46-50. PubMed ID: 7818549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.
    Nassar N; Horn G; Herrmann C; Scherer A; McCormick F; Wittinghofer A
    Nature; 1995 Jun; 375(6532):554-60. PubMed ID: 7791872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the Ras-binding domain of c-Raf-1 as determined by NMR spectroscopy and identification of the region that interacts with Ras.
    Emerson SD; Madison VS; Palermo RE; Waugh DS; Scheffler JE; Tsao KL; Kiefer SE; Liu SP; Fry DC
    Drug Des Discov; 1996 Apr; 13(3-4):83-93. PubMed ID: 8874046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
    Luo Z; Tzivion G; Belshaw PJ; Vavvas D; Marshall M; Avruch J
    Nature; 1996 Sep; 383(6596):181-5. PubMed ID: 8774885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues.
    Chuang E; Barnard D; Hettich L; Zhang XF; Avruch J; Marshall MS
    Mol Cell Biol; 1994 Aug; 14(8):5318-25. PubMed ID: 8035810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian Ras interacts directly with the serine/threonine kinase Raf.
    Vojtek AB; Hollenberg SM; Cooper JA
    Cell; 1993 Jul; 74(1):205-14. PubMed ID: 8334704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras.
    Ghosh S; Xie WQ; Quest AF; Mabrouk GM; Strum JC; Bell RM
    J Biol Chem; 1994 Apr; 269(13):10000-7. PubMed ID: 8144497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.